Bristol-Myers Settles Suit by Pharmacies
Bristol-Myers Squibb Co. settled a lawsuit filed by Walgreen Co., Safeway Inc. and other chain pharmacies over its efforts to block generic competition to its anti-anxiety drug BuSpar.
J.C. Penney Co.’s Eckerd drugstores, Kroger Co. and Albertson’s Inc. also were plaintiffs in the lawsuit, filed in New York in April. Bristol-Myers is in talks to settle a similar group of lawsuits filed by consumers. A company spokesman said details are confidential.
The lawsuits accused the New York-based drug maker of improperly using patents to block competition to buspirone, the active ingredient in BuSpar. As a result, the pharmacies said, they were forced to sell a higher-priced version of buspirone from 1995 to 2001. Bristol-Myers has said its actions were lawful.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.